The Cell Therapy Revolution

Are you going?

13 people going


Raffles City Tower - Office Space

250 North Bridge Rd · Singapore

How to find us

Level 21, Raffles City Tower, 250 North Bridge Road, Singapore 179101

Location image of event venue


Please Register Here:

The Cell Therapy Revolution

Presented by Singapore Economic Development Board, SGInnovate, Biotech Connection Singapore
Partnered with Enterprise Singapore, A*ccelerate

Join us on the 21st of this month as we explore the exciting field of cell therapies, including CAR-T and TCR-T cell therapies which display great potential to transform cancer treatment. This event will feature a keynote address by Novartis providing an overview of the topic of cell therapy and global developments in this area. A panel discussion by experts in the field will then delve into the details of the future promise of these therapies as well as current challenges in the field that may still need to be overcome.

The Cell Therapy Revolution kicks off the Singapore Biotech Insights event series co-organised by EDB, SGInnovate and Biotech Connection Singapore. This series of events aims to foster stronger connections within the local biotech community in Singapore through featuring several current and exciting topics in biotech. Thereby bringing together various stakeholders in the healthcare, tech and other sectors to participate in rich and enlightening discussions with experts in the field, and providing a networking platform to catalyse the formation of valuable new partnerships.

Please Register Here:

Date: 21 October 2019, Monday
Time: 5:00pm – 7:00pm
Venue: 250 North Bridge Road, Level 21 Raffles City Tower, Singapore[masked]

Keynote Speaker:
Dr Didier Dargent, Head of International Markets for Cell & Gene Therapy, Novartis Oncology

Dr Khoo Shih, Managing Director of Life Sciences Investments, Temasek
Prof Antonio Bertoletti, Scientific Director, Lion TCR and Professor, Duke-NUS Medical School
Dr Srinivasan N Kellathur, Director of Advanced Therapy Products Branch, Health Sciences Authority

Moderator: Chris Hardesty, Director of Life Sciences Practice, KPMG

Programme Details:
5:00pm – 5:20pm: Registration
5:20pm – 5:30pm: Keynote Address by Didier Dargent, Head of International Markets for Cell & Gene Therapy, Novartis Oncology
5:30pm – 6:30pm: Panel Discussion and Q&A
6:30pm – 7:00pm: Networking

Please Register Here: